Advertisement

Topics

Elderstreet Investments Limited Company Profile

03:31 EST 18th November 2017 | BioPortfolio

Elderstreet is a leading UK venture capital fund manager investing in early stage and development capital for UK growing businesses.
We provide funding for MBOs and development capital in most industry sectors and have a specialist technology practice investing in the software and computer services market.

Elderstreet has a strong investment performance record with investments typically in the range of £0.5 and £5m and we currently have over £80m of investors' funds offering investment products for institutional and retail investors through our limited partnership and tax-efficient funds

Location

2 Bedford Row
London
London
WC1R 4HE
United Kingdom

Contact

Phone: 44 (0) 20 7831 5088
Fax: 44 (0) 20 7831 5077
Email: admin@elderstreet.com


News Articles [58 Associated News Articles listed on BioPortfolio]

Appointment of Director

Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...

Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange

MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the developmen...

Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited

CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...

Telix Pharmaceuticals Limited Launches $50 Million Underwritten Initial Public Offering (ASX: TLX)

MELBOURNE, Australia, Oct. 23, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (Telix, the Company), an Australian biopharmaceutical company focused on the development of diagnostic and ...

Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference

JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Execut...

Quotient Limited Reports Second Quarter Fiscal 2018 Financial Results

MosaiQ project de-risked, Verification and Validation (“V&V”) “head-to-head” studies confirm targeted concordance levels for all blood grouping assaysEuropean field trials planned to co...

Takeda Research Investment: How Investments are Chosen

In this episode of PharmaTelevision News Review, Fintan Walton talks with Graeme Martin, President & CEO at Takeda Research Investment. Filmed at BioTrinity 2010 in Newbury, UK, they discuss: • TRI...

Quotient Limited to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference

JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...

PubMed Articles [53 Associated PubMed Articles listed on BioPortfolio]

Family Investments in Low-Income Children's Achievement and Socioemotional Functioning.

Family processes and parenting practices help explain developmental differences between children in low- versus higher-income households. There are, however, few studies addressing the question of: wh...

Planning future care services: Analyses of investments in Norwegian municipalities.

To analyse whether the Norwegian Central Government's goal of subsidizing 12,000 places in nursing homes or sheltered housing using an earmarked grant was reached and to determine towards which group ...

How excluding some benefits from value assessment of new drugs impacts innovation.

Payers often assess the benefits of new drugs relative to costs for reimbursement purposes, but they frequently exclude some drugs' option-related benefits, reducing their reimbursement chances, and m...

Financialisation in health care: An analysis of private equity fund investments in Turkey.

The 2007-2008 global financial crisis revived interest in the impacts of financial markets and actors on our social and economic life. Nevertheless, research on health care financialisation remains sc...

Matches and mismatches between conservation investments and biodiversity values in the European Union.

Recently, the European Commission adopted a new strategy to halt the loss of biodiversity. Member states are expected to favour a more effective collection and redistribution of European Union (EU) fu...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

CV Wizard: Does a Clinical Decision Support Tool Improve CVD Risk Factor Control in Safety Net Clinics?

This project aims to reduce disparities in cardiovascular disease (CVD) risk factor control and in rates of heart attacks and strokes among the low-income, racially / ethnically diverse Am...

Sanitation Demand Creation in Peri-Urban Slums of Lusaka, Zambia

This intervention will experimentally test the hypothesis that sanitation can be improved in a peri-urban setting using state-of-the-art behaviour change communications. Formative researc...

Modifying Young Adult Skin Cancer Risk and Protective Behaviors

Skin cancer is the most common cancer and can be deadly, debilitating, damaging, and disfiguring, yet is highly preventable. In 2014, the US Surgeon General made a call to action about the...

Companies [525 Associated Companies listed on BioPortfolio]

Elderstreet Investments Limited

Elderstreet is a leading UK venture capital fund manager investing in early stage and development capital for UK growing businesses. We provide funding for MBOs and development capital in most industr...

Elderstreet

Elderstreet is a leading UK venture capital firm specialising in early stage funding for high growth businesses predominantly in the European Software and Computer Services sector. In addition to our ...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

MGT Capital Investments, Inc.

MGT Capital Investments, Inc. is a holding company. The Company has two subsidiaries, Medicsight and Medicexchange.

More Information about "Elderstreet Investments Limited" on BioPortfolio

We have published hundreds of Elderstreet Investments Limited news stories on BioPortfolio along with dozens of Elderstreet Investments Limited Clinical Trials and PubMed Articles about Elderstreet Investments Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Elderstreet Investments Limited Companies in our database. You can also find out about relevant Elderstreet Investments Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record